Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Combining the ladder with index funds adds diversification and steadier cash flow, helping manage sequence of return risk over retirement.
28,657 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A plan to exempt overtime from income tax might attract attention for rewarding hard work, but it risks fairness, rev...
Memory-chip demand remains tight, and Micron's product mix positions it to benefit from AI adoption in data centers. ...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...
Meta wants cloud could shake up the cloud market and test Amazon's AWS dominance. This guide breaks down what that co...
As Netflix eyes growth beyond original programming, could this netflix's next move involve a strategic acquisition? T...
A record-breaking bid for SpaceX could reshape the opening trading landscape. Here’s how inflows of demand influence ...
A fresh stake in COPT Defense Properties signals a calculated tilt toward defense-related real estate. This article b...
Two oil giants linked to Guyana just posted a staggering combined profit. Here’s what investors need to know about pr...
Palantir stock investors just got new cues from the Street. This guide explains what the headlines might mean, how to...
As brookfield corp's next earnings approaches, investors weigh how the company will navigate its diverse asset mix. T...
When a major AI breach hit, Hugging Face found a fast, practical path by running a Chinese model locally. This decisi...